Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kadoya, Manabu ^a   Koyama, Hidenori ^a   Kanzaki, Akinori ^a   Kurajoh, Masafumi ^a   Hatayama, Miki ^a   Shiraishi, Jun ^a   Okazaki, Hirokazu ^a   Shoji, Takuhito ^a   Moriwaki, Yuji ^a   Yamamoto, Tetsuya ^a   Inaba, Masaaki ^b   Namba, Mitsuyoshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; CARDIAC AUTONOMIC FUNCTION; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PROTEIN BLOOD LEVEL; REGISTER; SMOKING; SYSTOLIC BLOOD PRESSURE; AUTONOMIC NERVOUS SYSTEM; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84920887844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105977     Document Type: Article

References (41)

1. Hohn A, Leibrock J, Bailey K, Barde YA (1990) Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344: 339-341.
2. Huang EJ, Reichardt LF (2001) Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24: 677-736. (Pubitemid 32695243)
3. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37: 1553-1561. (Pubitemid 28550429)
4. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, et al. (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470: 113-117. (Pubitemid 30151080)
5. Marosi K, Mattson MP (2014) BDNFmediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 25: 89-98.
6. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, et al. (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96: 15239-15244. (Pubitemid 30019796)
7. Bariohay B, Lebrun B, Moyse E, Jean A (2005) Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology 146: 5612-5620. (Pubitemid 41653078)
8. Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, et al. (2006) Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (bdnf) gene. Diabetes 55: 3366-3371. (Pubitemid 44923594)
9. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, et al. (2004) A de novo mutation affecting human trkb associated with severe obesity and developmental delay. Nat Neurosci 7: 1187-1189. (Pubitemid 39426236)
10. Brady R, Zaidi SI, Mayer C, Katz DM (1999) BDNF is a target-derived survival factor for arterial baroreceptor and chemoafferent primary sensory neurons. J Neurosci 19: 2131-2142. (Pubitemid 29133391)
11. Vermehren-Schmaedick A, Jenkins VK, Hsieh HY, Brown AL, Page MP, et al. (2013) Upregulation of brain-derived neurotrophic factor expression in nodose ganglia and the lower brainstem of hypertensive rats. J Neurosci Res 91: 220-229.
12. Wang H, Zhou XF (2002) Injection of brain-derived neurotrophic factor in the rostral ventrolateral medulla increases arterial blood pressure in anaesthetized rats. Neuroscience 112: 967-975. (Pubitemid 34667059)
13. Ejiri J, Inoue N, Kobayashi S, Shiraki R, Otsui K, et al. (2005) Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 112: 2114-2120. (Pubitemid 41475804)
14. Okada S, Yokoyama M, Toko H, Tateno K, Moriya J, et al. (2012) Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arterioscler Thromb Vasc Biol 32: 1902-1909.
15. Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L (2005) Reduced plasma levels of ngf and bdnf in patients with acute coronary syndromes. Int J Cardiol 102: 169-171. (Pubitemid 40812937)
16. Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, et al. (2010) Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: Data from the baltimore longitudinal study of aging. PLoS One 5:e10099.
17. Pickering TG. (1990) The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 81: 700-702.
18. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, et al. (2001) Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38: 852-857. (Pubitemid 34258682)
19. Okamoto LE, Gamboa A, Shibao C, Black BK, Diedrich A, et al. (2009) Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension 53: 363-369.
20. Takagi T, Ohishi M, Ito N, Kaibe M, Tatara Y, et al. (2006) Evaluation of morning blood pressure elevation and autonomic nervous activity in hypertensive patients using wavelet transform of heart rate variability. Hypertens Res 29: 977-987. (Pubitemid 46206584)
21. Kario K, Motai K, Mitsuhashi T, Suzuki T, Nakagawa Y, et al. (1997) Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation: Relation to silent cerebrovascular disease. Hypertension 30: 1504-1510. (Pubitemid 27528096)
22. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, et al. (2013) Executive summary of the japan atherosclerosis society (jas) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in japan -2012 version. J Atheroscler Thromb 20: 517-523.
23. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (Suppl 1):S5-S10.
24. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated gfr from serum creatinine in japan. Am J Kidney Dis 53: 982-992.
25. Sairaku A, Yoshida Y, Hirayama H, Nakano Y, Nanasato M, et al. (2013) Clinical significance of sleep-disordered breathing induced by sedatives during ablation of atrial fibrillation. Sleep Med 14: 622-627.
26. Rakugi H, Enya K, Sugiura K, Ikeda Y (2012) Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in japanese patients with grade i-ii essential hypertension: A randomized, double-blind clinical study. Hypertens Res 35: 552-558.
27. Eissa MA, Poffenbarger T, Portman RJ (2001) Comparison of the actigraph versus patients' diary information in defining circadian time periods for analyzing ambulatory blood pressure monitoring data. Blood Press Monit 6: 21-25. (Pubitemid 32269927)
28. Yoshida T, Yoshino A, Kobayashi Y, Inoue M, Kamakura K, et al. (2001) Effects of slow repetitive transcranial magnetic stimulation on heart rate variability according to power spectrum analysis. J Neurol Sci 184: 77-80. (Pubitemid 32166729)
29. Task force of the european society of cardiology and the north american society of pacing and electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17: 354-381.
30. Griesbach GS, Hovda DA, Gomez-Pinilla F, Sutton RL (2008) Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin i following cortical contusion injury in rats. Neuroscience 154: 530-540.
31. Kario K (2005) Time for focus on morning hypertension: Pitfall of current antihypertensive medication. Am J Hypertens 18: 149-151.
32. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, et al. (2008) Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension 52: 925-931.
33. Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328: 261-264. (Pubitemid 34876661)
34. Martin B, Pearson M, Kebejian L, Golden E, Keselman A, et al. (2007) Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess. Endocrinology 148: 4318-4333. (Pubitemid 47295690)
35. Yang B, Slonimsky JD, Birren SJ (2002) A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor. Nat Neurosci 5: 539-545. (Pubitemid 34568995)
36. Furmaga H, Carreno FR, Frazer A (2012) Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor trkb in rat brain. PLoS One 7:e34844.
37. Umetani K, Singer DH, McCraty R, Atkinson M (1998) Twenty-four hour time domain heart rate variability and heart rate: Relations to age and gender over nine decades. J Am Coll Cardiol 31: 593-601. (Pubitemid 28144127)
38. Orlov S, Bril V, Orszag A, Perkins BA (2012) Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes. Diabetes Care 35: 809-816.
39. Fujii H, Koyama H, Fukuda S, Tokai H, Tajima S, et al. (2013) Autonomic function is associated with health-related quality of life in patients with end-stage renal disease: A case-control study. J Renal Nutr 23: 340-347.
40. Yamaguchi K, Ohki N, Kobayashi M, Satoya N, Inoue Y, et al. (2004) Estimation of parasympathetic nerve function during sleep in patients with obstructive sleep apnea by instantaneous time-frequency analysis. Sleep Med 15: 33-41.
41. Mogensen UM, Jensen T, Kober L, Kelbaek H, Mathiesen AS, et al. (2012) Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes 61: 1822-1830.